Table 1.
Main characteristics of the whole study population, divided by ventilated and non-ventilated patients.
| Baseline Variables | All Patients (n = 15) (%) |
Ventilated (n = 6 (40%)) |
Non-Ventilated (n = 9 (60%)) |
p-Value |
|---|---|---|---|---|
| Gender (F) | 7 (46.7%) | 2 (33%) | 5 (55.6%) | 0.002 |
| Age (years) | 69.0 ± 18.6 | 61.0 ± 8.5 | 67.4 ± 18.7 | 0.329 |
| SBP (mmHg) | 79.5± 8.5 | 70.1 ± 9.4 | 87 ± 9.1 | 0.038 |
| Hb (g/dL) | 12.0 ± 2.0 | 10.5 ± 1.8 | 12.1 ± 2.1 | 0.128 |
| BNP (mmol/L) | 971,6 | 989.0 ± 217.0 | 1036.7 ± 325.0 | 0.750 |
| HS Trop (mmol/L) | 37,692.9 ± 86,529.8 | 57,867.0 ± 109,964.0 | 4334.0 ± 7993.0 | 0.659 |
| CRP (mmol/L) | 31.8 ± 60.1 | 99.5 ± 79.8 | 27.5 ± 53.3 | 0.047 |
| STEMI, n (%) | 6 (40%) | 2 (33.3%) | 4 (44.4%) | 0.0008 |
| CHF, n (%) | 5 (33%) | 2 (33.3%) | 3 (33.3%) | 0.0004 |
| Other, n (%) | 4 (26.7%) | 2 (33.3%) | 2 (22%) | 0.0004 |
| Diabetes, n (%) | 4 (26.7%) | 3 (50%) | 1 (11%) | 0.177 |
| Hypertension, n (%) | 7 (46.7%) | 4 (66.7%) | 3 (33.3%) | 0.061 |
| Hypercholesterolemia, n (%) | 10 (66.7%) | 6 (100%) | 4 (44.4%) | 0.218 |
| Chronic Kidney Disease, n (%) | 3 (20%) | 0 | 3 (33.3%) | <0.000001 |
| Valvular Regurgitation, n (%) | 6 (40%) | 1 (16.7%) | 5 (55.6%) | 0.00008 |
SBP: Systolic Blood Pressure; Hb: Hemoglobin BNP: Brain Natriuretic Peptide; HsTrop: Hight Sensitivity Troponin; CRP: C-Reactive Protein; STEMI: ST-segment elevation myocardial infarction; CHF: Chronic Heart Failure.